Cargando…
The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway
The diabetes medication canagliflozin (Cana) is a sodium glucose cotransporter 2 (SGLT2) inhibitor acting by increasing urinary glucose excretion and thus reducing hyperglycaemia. Cana treatment also reduces body weight. However, it remains unclear whether Cana could directly work on adipose tissue....
Autores principales: | Yang, Xuping, Liu, Qinhui, Li, Yanping, Tang, Qin, Wu, Tong, Chen, Lei, Pu, Shiyun, Zhao, Yingnan, Zhang, Guorong, Huang, Cuiyuan, Zhang, Jinhang, Zhang, Zijing, Huang, Ya, Zou, Min, Shi, Xiongjie, Jiang, Wei, Wang, Rui, He, Jinhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469612/ https://www.ncbi.nlm.nih.gov/pubmed/32835596 http://dx.doi.org/10.1080/21623945.2020.1807850 |
Ejemplares similares
-
Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter Pathway
por: Zhao, Yingnan, et al.
Publicado: (2021) -
Sirt6 in pro-opiomelanocortin neurons controls energy metabolism by modulating leptin signaling
por: Tang, Qin, et al.
Publicado: (2020) -
Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells
por: Zhang, Jinhang, et al.
Publicado: (2020) -
Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
por: Pu, Shiyun, et al.
Publicado: (2019) -
Farnesylthiosalicylic Acid-Loaded Albumin Nanoparticle Alleviates Renal Fibrosis by Inhibiting Ras/Raf1/p38 Signaling Pathway
por: Huang, Hui, et al.
Publicado: (2021)